CI insider transaction filings
Cigna Group — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-08. Screen CI transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 6 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings by 2 insiders — 22,730 shares, $6,293,359 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 19,436 shares @ $276.27 ($5,369,584) by Jones Nicole S, filed 2026-08-06.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Jones Nicole S — See Remarks | 2 | — | 2 legs · 22,113 sh · $6,118,100 | 4 |
| Neville Everett — See Remarks | 1 | — | 1 leg · 617 sh · $175,259 | — |
| Holgerson Bryan — See Remarks | 1 | — | — | 3 |
| Evanko Brian C — See Remarks | 1 | — | — | 2 |
| Kurian George — Director | 1 | — | — | 1 |
Recent Form 4 filings — Cigna Group
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Neville Everett — See Remarks | Sale (S): 617 @ $284.05 | EDGAR |
| 2026-09-03 | 4 | Evanko Brian C — See Remarks | Grant/award (A): 3,113 @ $0 · Grant/award (A): 6,716 (derivative) @ $0 | EDGAR |
| 2026-09-02 | 4 | Kurian George — Director | Grant/award (A): 108.66 (derivative) @ $276.08 | EDGAR |
| 2026-08-20 | 4 | Holgerson Bryan — See Remarks | Grant/award (A): 0.89 (derivative) @ $291.80 · Grant/award (A): 0.95 (derivative) @ $286.29 · Grant/award (A): 0.98 (derivative) @ $275.25 | EDGAR |
| 2026-08-20 | 4 | Jones Nicole S — See Remarks | Sale (S): 2,677 @ $279.61 | EDGAR |
| 2026-08-06 | 4 | Jones Nicole S — See Remarks | Option exercise (M): 14,045 @ $192.02 · Sale (S): 19,436 @ $276.27 · Option exercise (M): 1,301 @ $192.02 · Option exercise (M): 14,045 (derivative) @ $0 · Option exercise (M): 1,301 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Kates Jamie G — Chief Accounting Officer | Option exercise (M): 899 @ $152.89 · Sale (S): 899 @ $298.61 · Option exercise (M): 899 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Koka Durga Prasad — EVP, Global CIO | Tax withholding (F): 729 @ $275.53 | EDGAR |
| 2026-06-02 | 4 | Kurian George — Director | Grant/award (A): 108.15 (derivative) @ $277.40 | EDGAR |
| 2026-05-14 | 4 | Cordani David — Chairman & CEO, Director | Option exercise (M): 103,595 @ $149.13 · Option exercise (M): 85,519 @ $197.35 · Sale (S): 3,903 @ $286.83 · Sale (S): 14,292 @ $287.96 · Sale (S): 13,839 @ $288.85 · Sale (S): 41,099 @ $290.00 · +15 more | EDGAR |
| 2026-04-24 | 4 | Hathi Neesha — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | Ozuah Philip — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | Kurian George — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | McClellan Mark B. — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | Ross Kimberly A. — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | Hennigan Michael J — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | MAZZARELLA KATHLEEN M — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | ZARCONE DONNA F — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | WISEMAN ERIC C — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-04-24 | 4 | FOSS ERIC J — Director | Grant/award (A): 782 @ $0 | EDGAR |
| 2026-03-03 | 4 | Kates Jamie G — Chief Accounting Officer | Grant/award (A): 205 @ $0 · Grant/award (A): 609 @ $0 · Tax withholding (F): 71 @ $287.55 · Tax withholding (F): 61 @ $287.55 · Grant/award (A): 657 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Koka Durga Prasad — EVP, Global CIO | Grant/award (A): 499 @ $0 · Grant/award (A): 2,678 @ $0 · Tax withholding (F): 122 @ $287.55 · Tax withholding (F): 98 @ $287.55 · Grant/award (A): 4,127 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Evanko Brian C — See Remarks | Grant/award (A): 6,428 @ $0 · Grant/award (A): 9,787 @ $0 · Tax withholding (F): 2,979 @ $287.55 · Tax withholding (F): 1,788 @ $287.55 · Grant/award (A): 15,082 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | DENNISON ANN M — EVP, CFO | Grant/award (A): 5,234 @ $0 · Tax withholding (F): 409 @ $287.55 · Grant/award (A): 8,066 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Neville Everett — See Remarks | Grant/award (A): 2,602 @ $0 · Grant/award (A): 2,678 @ $0 · Tax withholding (F): 883 @ $287.55 · Tax withholding (F): 517 @ $287.55 · Sale (S): 1,719 @ $288.91 · Grant/award (A): 4,127 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Kurian George — Director | Grant/award (A): 103.51 (derivative) @ $289.82 | EDGAR |
| 2026-03-03 | 4 | Jones Nicole S — See Remarks | Grant/award (A): 4,133 @ $0 · Grant/award (A): 5,234 @ $0 · Tax withholding (F): 1,826 @ $287.55 · Tax withholding (F): 912 @ $287.55 · Sale (S): 2,307 @ $288.91 · Grant/award (A): 8,066 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Cordani David — Chairman & CEO, Director | Grant/award (A): 23,788 @ $0 · Grant/award (A): 17,389 @ $0 · Tax withholding (F): 11,024 @ $287.55 · Tax withholding (F): 4,408 @ $287.55 · Grant/award (A): 37,516 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Kurian George — Director | Grant/award (A): 108.19 (derivative) @ $108.19 | EDGAR |
| 2025-11-03 | 4 | Cordani David — Chairman & CEO, Director | Purchase (P): 4,134 @ $241.88 | EDGAR |
| 2025-10-07 | 4 | Evanko Brian C — See Remarks | Option exercise (M): 5,368 @ $139.22 · Sale (S): 5,368 @ $300 · Option exercise (M): 901 @ $139.22 · Option exercise (M): 5,368 (derivative) @ $0 · Option exercise (M): 901 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Kurian George — Director | Grant/award (A): 99.71 (derivative) @ $300.87 | EDGAR |
| 2025-09-03 | 4 | BRAILER DAVID J — EVP & Chief Health Officer | Tax withholding (F): 290 @ $300.66 | EDGAR |
| 2025-08-19 | 4 | Jones Nicole S — See Remarks | Option exercise (M): 13,155 @ $197.35 · Option exercise (M): 11,598 @ $183.44 · Sale (S): 28,526 @ $300 · Option exercise (M): 1,348 @ $183.44 · Option exercise (M): 1,329 @ $197.35 · Option exercise (M): 11,598 (derivative) @ $0 · +3 more | EDGAR |
| 2025-06-04 | 4 | Hennigan Michael J — Director | Grant/award (A): 568 @ $0 | EDGAR |
| 2025-06-03 | 4 | Kurian George — Director | Grant/award (A): 94.74 (derivative) @ $316.64 | EDGAR |
| 2025-04-25 | 4 | Ozuah Philip — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | Hathi Neesha — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | Granger Elder — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | Kurian George — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | McClellan Mark B. — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | Ross Kimberly A. — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | MAZZARELLA KATHLEEN M — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | ZARCONE DONNA F — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | WISEMAN ERIC C — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-04-25 | 4 | FOSS ERIC J — Director | Grant/award (A): 638 @ $0 | EDGAR |
| 2025-03-17 | 4 | Granger Elder — Director | Option exercise (M): 2,376 @ $151.48 · Sale (S): 2,376 @ $310.35 · Option exercise (M): 2,376 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Eder Noelle K — See Remarks | Sale (S): 9,944 @ $320 | EDGAR |
| 2025-03-04 | 4 | Cordani David — Chairman & CEO, Director | Grant/award (A): 49,437 @ $0 · Grant/award (A): 11,117 @ $0 · Tax withholding (F): 4,696 @ $305.86 · Tax withholding (F): 22,910 @ $305.86 · Sale (S): 26,527 @ $308.12 · Grant/award (A): 39,476 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | BRAILER DAVID J — EVP & Chief Health Officer | Grant/award (A): 6,540 @ $0 · Grant/award (A): 5,640 @ $0 · Tax withholding (F): 775 @ $305.86 · Tax withholding (F): 2,632 @ $305.86 · Grant/award (A): 23,222 (derivative) @ $0 | EDGAR |
Recent 8-K events — Cigna Group
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-03-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-27 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-02-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-18 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →